Abstract:Objective To investigate the clinical manifestations,diagnostic methods and treatment of severe combined immunodeficiency (SCID).Methods The patient presented at the age of 2 months with frequent pneumonia and a history of chronic oral candidiasis even when treated adequately with antibiotics or anti-fungi agents. Flow cytometric analysis was used to assess T cells. Cell surface markers of peripheral blood cells were determined by immunofluorescent staining and flow cytometry with antibodies purchased from BD company. IL-2R gene was analyzed by PCR and sequence was performed for the patient and partial maternal family members. Clinical documented information of the patient and his uncle died during early life was reviewed. His peripheral blood mononuclear cells were incubated at 37 ℃ in complete culture medium RPMI-1640. Cells were incubated in round bottom tissue culture plates with PHA for 72 h, and 18-20 hours before termination of the culture, thymidine was added to each well. The cells were then harvested and samples were counted in a liquid scintillation counter.Results The patient had a very low T-cell number. Initial investigations revealed a total white blood cell count of 2.8×109·L-1 [reference range, (5.4-9.4)×109·L-1] with a lymphocyte count of 1.9×109·L-1 [reference range, (2.8-5.7)×109·L-1], the results of flow cytometric analysis showed CD3+0, CD4+0, CD8+0, CD19+ 95%, CD16+CD56+ 4%. Sequencing of his IL-2RG revealed a G deletion at 849 in exon 6, the consequence showed frameshift start form cysteine 278, "TGA" stop codon created at position 293. His mother was confirmed to be a carrier, she didn't seem to be a simple heterozygote,but maybe mosaic mutation with mixed population in leucocytes. His uncle died of severe incurable infection and without mononuclear proliferation to PHA stimulation. He presented hyperpyrexia, rash and splenohepatomegalia after recieving transfusion of untreated fresh blood. Considering his family history, his uncle's clinical manifestation was high likely due to graft versus host disease. IL2R gene analysis was also done for his newborn sister after family survey.His sister was confirmed to be the same mutation as her mother.Conclusions Genetic diagnosis was made for one X-SCID patient caused by IL-2RG. And after family survey, his mother and sister were confirmed to be carriers, maybe mosaic mutation with mixed population in leucocytes. Infant with severe infection even after treated with adequate standard treatment, should be considered the possibility of suffering SCID and immune function evaluation should be taken. As the underlying severe disorders, the living vaccine and untreated blood products transfusion must be restrained. Early immune reconstitution including bone marrow or stem cell transplantation offers the best chance of long-term survival. Medical workers should pay more attention to immunodeficiency.

[Advances in Newborn Screening and Immune System Reconstitution of Severe Combined Immunodeficiency].

Efficient screening strategies for severe combined immunodeficiencies in newborns

[Newborn screening for severe combined immunodeficiencies (SCID) in Germany]

A Unique Comprehensive Model to Screen Newborns for Severe Combined Immunodeficiency-An Ontario Single-Centre Experience Spanning 2013-2023

Why newborn screening for severe combined immunodeficiency is essential: a case report

Severe combined immunodeficiency diagnosis and genetic defects

A report of two cases of severe X-linked combined immunodeficiency in one family and literature review

Genetically-determined defects of T cell development

Reducing Mortality and Morbidity in Children with Severe Combined Immunodeficiency in Switzerland: the Role of Newborn Screening

Late effects following hematopoietic cell transplantation for severe combined immunodeficiency: critical factors and therapeutic options

Severe combined immunodeficiency with a homozygous c.464T>C (p.Leu155Pro) mutation in the RAG2 gene in a country without neonatal screening: Report of two clinical cases

Survival After Hematopoietic Stem Cell Transplantation in Severe Combined Immunodeficiency (SCID): A Worldwide Review of the Prognostic Variables

A novel pathogenic mutation on Interleukin-7 receptor leading to severe combined immunodeficiency identified with newborn screening and whole exome sequencing

Hematopoietic Stem Cell Transplantation for Combined Immunodeficiencies, on Behalf of IEWP-EBMT

A Large Cohort of RAG1/2-Deficient SCID Patients—Clinical, Immunological, and Prognostic Analysis

Unrelated cord blood transplantation using minimal-intensity conditioning in a 1.5-month-old infant with X-linked severe combined immunodeficiency

Paving the way in implementation of SCID newborn screening in developing nations: feasibility study and strategies to move forward in Malaysia

Clinical and economic aspects of newborn screening for severe combined immunodeficiency: DEPISTREC study results

Poor T-cell receptor β repertoire diversity early posttransplant for severe combined immunodeficiency predicts failure of immune reconstitution

Progress in the field of hematopoietic stem cell-based therapies for inborn errors of immunity

HCT in the widening spectrum of congenital immunodeficiencies